Cost impact analysis of novel host-response diagnostic for patients with community-acquired pneumonia in the emergency department

References

• Ferreira-Coimbra J, Sarda C, Rello J. Burden of community-acquired pneumonia and unmet clinical needs. Adv Ther. 2020;37(4):1302–1318.
   PubMed Web of Science ®Google Scholar
• Divino V, Schranz J, Early M, et al. The 1-year economic burden of community-acquired pneumonia (CAP) initially managed in the outpatient setting in the USA. J Comp Eff Res. 2020;9(2):127–140.
   PubMed Web of Science ®Google Scholar
• Stupka JE, Mortensen EM, Anzueto A, et al. Community-acquired pneumonia in elderly patients. Aging Health. 2009;5(6):763–774.
   PubMedGoogle Scholar
• Jain S, Self WH, Wunderink RG, et al. Community-acquired pneumonia requiring hospitalization among U.S. adults. N Engl J Med. 2015;373(5):415–427.
   PubMed Web of Science ®Google Scholar
• Metlay JP, Waterer GW, Long AC, et al. Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and infectious diseases society of america. Am J Respir Crit Care Med. 2019;200(7):e45–e67.
   PubMed Web of Science ®Google Scholar
• Saeed K, Wilson DC, Bloos F, et al. The early identification of disease progression in patients with suspected infection presenting to the emergency department: a multi-Centre derivation and validation study. Critical Care. 2019;23(1):40.
   PubMed Web of Science ®Google Scholar
• Huijskens EGW, Koopmans M, Palmen FMH, et al. The value of signs and symptoms in differentiating between bacterial, viral and mixed aetiology in patients with community-acquired pneumonia. J Med Microbiol. 2014;63(Pt 3):441–452.
   PubMedGoogle Scholar
• Battle of the bugs: fighting antibiotic resistance. US Food and Drug Administration; 2016.
   Google Scholar
• Klompas M, Ochoa A, Ji W, et al. Prevalence of clinical signs within reference ranges among hospitalized patients prescribed antibiotics for pneumonia. JAMA Netw Open. 2020;3(7):e2010700.
   PubMed Web of Science ®Google Scholar
• Tamma PD, Avdic E, Li DX, et al. Association of adverse events with antibiotic use in hospitalized patients. JAMA Intern Med. 2017;177(9):1308–1315.
   PubMed Web of Science ®Google Scholar
• Ashkenazi-Hoffnung L, Oved K, Navon R, et al. A host-protein signature is superior to other biomarkers for differentiating between bacterial and viral disease in patients with respiratory infection and fever without source: a prospective observational study. Eur J Clin Microbiol Infect Dis. 2018;37(7):1361–1371.
   PubMed Web of Science ®Google Scholar
• Eden E, Srugo I, Gottlieb T, et al. Diagnostic accuracy of a TRAIL, IP-10 and CRP combination for discriminating bacterial and viral etiologies at the emergency department. J Infect. 2016;73(2):177–180.
   PubMed Web of Science ®Google Scholar
• Stein M, Lipman-Arens S, Oved K, et al. A novel host-protein assay outperforms routine parameters for distinguishing between bacterial and viral lower respiratory tract infections. Diagn Microbiol Infect Dis. 2018;90(3):206–213.
   PubMed Web of Science ®Google Scholar
• Oved K, Cohen A, Boico O, et al. A novel host-proteome signature for distinguishing between acute bacterial and viral infections. PLOS One. 2015;10(3):e0120012.
   PubMed Web of Science ®Google Scholar
• Srugo I, Klein A, Stein M, et al. Validation of a novel assay to distinguish bacterial and viral infections. Pediatrics. 2017;140(4):e20163453.
   PubMed Web of Science ®Google Scholar
• van Houten CB, de Groot JAH, Klein A, et al. A host-protein based assay to differentiate between bacterial and viral infections in preschool children (OPPORTUNITY): a double-blind, multicentre, validation study. Lancet Infect Dis. 2017;17(4):431–440.
   PubMed Web of Science ®Google Scholar
• Havers FP, Hicks LA, Chung JR, et al. Outpatient antibiotic prescribing for acute respiratory infections during influenza seasons. JAMA Netw Open. 2018;1(2):e180243.
   PubMed Web of Science ®Google Scholar
• Ruiz-González A, Falguera M, Vives M, et al. Community-acquired pneumonia: development of a bedside predictive model and scoring system to identify the aetiology. Respir Med. 2000;94(5):505–510.
   PubMed Web of Science ®Google Scholar
• Schuetz P, Wirz Y, Sager R, et al. Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis. Lancet Infect Dis. 2018;18(1):95–107.
   PubMed Web of Science ®Google Scholar
• Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997;336(4):243–250.
   PubMed Web of Science ®Google Scholar
• Lodise TP, Van Le H, LaPensee K. Hospital admission patterns in adult patients with community-acquired pneumonia who received ceftriaxone and a macrolide by disease severity across United States hospitals. Antibiotics. 2020;9(9)577.
   Google Scholar
• Lin RY, Nuruzzaman F, Shah SN. Incidence and impact of adverse effects to antibiotics in hospitalized adults with pneumonia. J Hosp Med. 2009;4(2):E7–15.
   PubMedGoogle Scholar
• Zhang S, Palazuelos-Munoz S, Balsells EM, et al. Cost of hospital management of clostridium difficile infection in United States-a meta-analysis and modelling study. BMC Infect Dis. 2016;16(1):447–447.
   PubMed Web of Science ®Google Scholar
• Wu X, Wang Q, Wang M, et al. Incidence of respiratory viral infections detected by PCR and real-time PCR in adult patients with community-acquired pneumonia: a meta-analysis. Respiration. 2015;89(4):343–352.
   PubMed Web of Science ®Google Scholar
• Palms DL, Hicks LA, Bartoces M, et al. Comparison of antibiotic prescribing in retail clinics, urgent care centers, emergency departments, and traditional ambulatory care settings in the United States. JAMA Intern Med. 2018;178(9):1267–1269.
   PubMed Web of Science ®Google Scholar
• A novel, rapid host-response test permits accurate differentiation of bacterial and viral infection in febrile ambulatory patients: Apollo study. In Progress.
   Google Scholar
• Appropriate use of Short-Course antibiotics in common infections: best practice advice from the American College of Physicians. Annals Internal Med. 2021;174(6):822–827.
   PubMed Web of Science ®Google Scholar
• Bonine NG, Berger A, Altincatal A, et al. Impact of delayed appropriate antibiotic therapy on patient outcomes by antibiotic resistance status from serious gram-negative bacterial infections. Am J Med Sci. 2019;357(2):103–110.
   PubMed Web of Science ®Google Scholar
• Broyles MR. Impact of Procalcitonin-Guided antibiotic management on antibiotic exposure and outcomes: real-world evidence. Open Forum Infectious Diseases. 2017;4(4):ofx213
   PubMed Web of Science ®Google Scholar
• Stuart B, Hounkpatin H, Becque T, et al. Delayed antibiotic prescribing for respiratory tract infections: individual patient data meta-analysis. BMJ. 2021;373:n808.
   PubMedGoogle Scholar
• Agency NPaS. Procalcitonin to differentiate bacterial lower respiratory tract infections from non-bacterial causes. Economic Report: NHS; 2010.
   Google Scholar
• Giuliano C, Patel CR, Kale-Pradhan PB. A guide to bacterial culture identification and results interpretation. P T. 2019;44(4):192–200.
   PubMedGoogle Scholar
• Su C-P, Chen TH-H, Chen S-Y, et al. Predictive model for bacteremia in adult patients with blood cultures performed at the emergency department: a preliminary report. J Microbiol Immunol Infect. 2011;44(6):449–455.
   PubMedGoogle Scholar
• Dall C. Pneumonia patients get too many antibiotics, study finds. Antimicrobial Stweardship. 2019. Available from: https://www.cidrap.umn.edu/news-perspective/2019/07/pneumonia-patients-get-too-many-antibiotics-study-finds.
   Google Scholar
• Chalmers JD, Akram AR, Singanayagam A, et al. Risk factors for clostridium difficile infection in hospitalized patients with community-acquired pneumonia. J Infect. 2016;73(1):45–53.
   PubMed Web of Science ®Google Scholar
• Physician Fee Report. 2019. Context4 Healthcare, Inc.
   Google Scholar
• Tong S, Amand C, Kieffer A, et al. Trends in healthcare utilization and costs associated with pneumonia in the United States during 2008–2014. BMC Health Serv Res. 2018;18(1):715.
   PubMedGoogle Scholar
• HCUPnet. Healthcare cost and utilization project (HCUP), agency for healthcare research and quality. Rockville, MD 2017. [cited 2021 Feb 21]. Available from: http://hcupnet.ahrq.gov/
   Google Scholar
• Pfoh E, Wessels MR, Goldmann D, et al. Burden and economic cost of group a streptococcal pharyngitis. Pediatrics. 2008;121(2):229–234.
   PubMed Web of Science ®Google Scholar
• Voermans AM, Mewes JC, Broyles MR, et al. Cost-Effectiveness analysis of a Procalcitonin-Guided decision algorithm for antibiotic stewardship using Real-World U.S. Hospital Data. OMICS. 2019;23(10):508–515.
   PubMed Web of Science ®Google Scholar
• Shorr AF, Zilberberg MD, Micek ST, et al. Viruses are prevalent in non-ventilated hospital-acquired pneumonia. Respir Med. 2017;122:76–80.
   PubMed Web of Science ®Google Scholar
• Menéndez R, Torres A, Reyes S, et al. Initial management of pneumonia and sepsis: factors associated with improved outcome. Eur Respir J. 2012;39(1):156–162.
   PubMed Web of Science ®Google Scholar
• Ahmad M, Khan AU. Global economic impact of antibiotic resistance: a review. J Glob Antimicrob Resist. 2019;19:313–316.
   PubMed Web of Science ®Google Scholar
• Antibiotic Resistance World Health Organization Newsroom: WHO; 2020 [cited 2021]. Available from: https://www.who.int/news-room/fact-sheets/detail/antibiotic-resistance.
   Google Scholar
• Friedman ND, Temkin E, Carmeli Y. The negative impact of antibiotic resistance. Clin Microbiol Infect. 2016;22(5):416–422.
   PubMed Web of Science ®Google Scholar